Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEA
3001
Easterly Government Properties
DEA
$1.17B
| $2.88M | ﹤0.01% |
53,890
+4,169
| +8% | +$218K |
|
3002
Renasant Corp
RNST
$3.98B
| $2.87M | ﹤0.01% |
70,270
+16,946
| +32% | +$708K |
|
3003
CALL
Labcorp
LH
$25.8B
| $2.87M | ﹤0.01% |
20,952
-4,889
| -19% | -$646K |
|
3004
Park Hotels & Resorts
PK
$3.05B
| $2.87M | ﹤0.01% |
99,665
-1,298,416
| -93% | -$37.2M |
|
3005
Centene
CNC
$33.3B
| $2.86M | ﹤0.01% |
+56,734
| New | +$2.75M |
|
|
TTM
3006
CALL
DELISTED
Tata Motors Limited
TTM
| $2.86M | ﹤0.01% |
86,500
+12,500
| +17% | +$404K |
|
|
QUOT
3007
DELISTED
Quotient Technology Inc
QUOT
| $2.86M | ﹤0.01% |
243,317
+159,755
| +191% | +$2.22M |
|
|
VTLE
3008
DELISTED
Vital Energy
VTLE
| $2.86M | ﹤0.01% |
13,466
+5,372
| +66% | +$1.18M |
|
|
TVTY
3009
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.86M | ﹤0.01% |
78,200
+45,639
| +140% | +$1.73M |
|
|
TRTN
3010
PUT
DELISTED
Triton International Limited
TRTN
| $2.86M | ﹤0.01% |
76,300
+42,700
| +127% | +$1.64M |
|
|
DOOR
3011
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.85M | ﹤0.01% |
38,499
+22,332
| +138% | +$1.56M |
|
|
MLNX
3012
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.85M | ﹤0.01% |
44,100
+15,100
| +52% | +$798K |
|
3013
PUT
Brunswick
BC
$5.36B
| $2.85M | ﹤0.01% |
51,600
+43,100
| +507% | +$2.35M |
|
3014
Diodes
DIOD
$4.77B
| $2.85M | ﹤0.01% |
99,313
-5,377
| -5% | -$167K |
|
3015
PUT
L3Harris
LHX
$54.3B
| $2.85M | ﹤0.01% |
20,100
+6,000
| +43% | +$838K |
|
|
FISV
3016
PUT
Fiserv Inc
FISV
$28.9B
| $2.85M | ﹤0.01% |
43,400
+39,200
| +933% | +$2.53M |
|
3017
PUT
Energous
WATT
$86M
| $2.85M | ﹤0.01% |
244
+43
| +21% | +$270K |
|
3018
Barnes & Noble Education
BNED
$421M
| $2.85M | ﹤0.01% |
3,453
-1,113
| -24% | -$736K |
|
|
SC
3019
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.85M | ﹤0.01% |
152,800
+43,100
| +39% | +$721K |
|
3020
PUT
iShares MSCI India ETF
INDA
$6.56B
| $2.84M | ﹤0.01% |
78,700
+54,100
| +220% | +$1.88M |
|
3021
First Commonwealth Financial
FCF
$2.18B
| $2.84M | ﹤0.01% |
198,048
-84,486
| -30% | -$1.22M |
|
3022
PTC Therapeutics
PTCT
$5.98B
| $2.84M | ﹤0.01% |
+170,031
| New | +$2.88M |
|
3023
PUT
Lennox International
LII
$14.6B
| $2.83M | ﹤0.01% |
13,600
+10,400
| +325% | +$2.03M |
|
3024
Barclays
BCS
$94.7B
| $2.83M | ﹤0.01% |
271,071
+125,772
| +87% | +$1.22M |
|
3025
CALL
Westlake Corp
WLK
$10.2B
| $2.82M | ﹤0.01% |
26,500
-7,100
| -21% | -$658K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.